Sorry, you need to enable JavaScript to visit this website.

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts Details
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    The Value of axitinib in combination with Immuno-oncology (IO) in Patients with Metastatic Renal Cell Carcinoma (mRCC)
    Release Date:
    Review Process: Pfizer Internal
    Research Oncology China
    Innovative Digital Health Projects to increase the Quality of Life (QoL) of Multiple Myeloma (MM) patients
    Release Date:
    Review Process: Expert Review Panel
    Quality Improvement Oncology Italy
    2024 RD Global Monitoring anti-TFPI RES
    Release Date:
    Review Process: Pfizer Internal
    Research Rare Disease All
    Call for Independent Medical Education Grant Applications Oncology – Urothelial Carcinoma (UC)
    Release Date:
    Partner: Astellas
    Review Process: Pfizer Internal
    Education Oncology All
    Health Services Research to Improve Management of mBC Patients Treated with Tucatinib
    Release Date:
    Review Process: Pfizer Internal
    Research Oncology All
    Addressing Multiple Myeloma Gaps in Care for Patients in Latin America
    Release Date:
    Partner: International Myeloma Foundation
    Review Process: Expert Review Panel
    Education Oncology Argentina, Brazil, Colombia, Mexico
    Providing Appropriate Medical Care for IBD Patients
    Release Date:
    Partner: Japanese Society for Inflammatory Bowel Disease (JSIBD)
    Review Process: Expert Review Panel
    Translation: Japanese (link)
    Quality Improvement Inflammation & Immunology Japan
    Management of Atopic Dermatitis / Alopecia Areata
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology USA
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Treatment Optimization in ALK-positive Metastatic Non-Small Cell Lung Cancer
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology Austria, Belgium, Canada, Denmark, Finland, France, Germany, Greece, Iceland, Italy, Netherlands, Norway, Portugal, Spain, Swaziland, Sweden, USA, United Kingdom
    Immunotherapy in High-risk Non-Muscle Invasive Bladder Cancer
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    Advances in Migraine Treatment
    Release Date:
    Review Process: Pfizer Internal
    Education Internal Medicine All
    2022/2023 Global Obesity ASPIRE
    Release Date:
    Review Process: Expert Review Panel
    Research Internal Medicine All
    Evolving Concepts in Biosimilar Optimization in Inflammatory Diseases
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology USA
    Underlying medical conditions and other risk factors, higher risk of severe COVID-19 (European)
    Release Date:
    Review Process: Pfizer Internal
    Education Hospital All
    Building Capacity to Address Health Disparities in the US through AMS Telehealth and Tele-mentoring
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Hospital USA
    2022/2023 Global NASH ASPIRE
    Release Date:
    Review Process: Expert Review Panel
    Research Internal Medicine All
    2023 Growth Hormone Research
    Release Date:
    Review Process: Pfizer Internal
    Research Rare Disease All
    Antimicrobial Resistance Testing and Stewardship to Improve Hospitalized Patients’ Health Outcomes
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Hospital All
    Medication Error Reduction Strategies in the Hospital Setting
    Release Date:
    Review Process: Pfizer Internal
    Education Hospital USA
    2022/2023 Global Cachexia ASPIRE
    Release Date:
    Review Process: Expert Review Panel
    Research Internal Medicine All